Press release
Age-related Macular Degeneration Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Opthea, Kodiak Sciences, Regenxbio, Alexion, AstraZeneca, Allegro, Apellis, Iveri
Age-related Macular Degeneration Pipeline
"Age-related Macular Degeneration Pipeline Insight, 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Age-related Macular Degeneration Therapeutics Market.
The Age-related Macular Degeneration Pipeline report provides a detailed description of the Age-related Macular Degeneration drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Age-related Macular Degeneration Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Age-related Macular Degeneration (AMD) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Age-related Macular Degeneration therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Age-related Macular Degeneration treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Age-related Macular Degeneration drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Age-related Macular Degeneration treatment market.
Learn More about the Clinical and Commercial Development Activities in the Age-related Macular Degeneration Therapeutics Domain @
https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Age-related Macular Degeneration Therapeutics Analysis
Age-related Macular Degeneration Therapeutics Analysis reveals a multifaceted landscape marked by innovative research and a spectrum of treatment modalities aimed at addressing this prevalent cause of vision loss. Therapies for AMD primarily bifurcate into two categories: anti-vascular endothelial growth factor (anti-VEGF) drugs and emerging treatments targeting alternative pathways involved in AMD progression. Anti-VEGF agents like ranibizumab, aflibercept, and bevacizumab have been pivotal in managing neovascular or "wet" AMD by inhibiting abnormal blood vessel growth in the retina.
However, challenges persist, including the need for frequent injections and resistance to treatment in some patients. Researchers are exploring diverse approaches, such as sustained-release drug delivery systems, gene therapies, complement inhibitors, and regenerative medicine, aiming to develop longer-lasting treatments and address different subtypes of AMD. The landscape is also witnessing a shift towards personalized medicine, leveraging genetic insights to tailor therapies based on individual patient characteristics. Clinical trials are investigating novel targets and combination therapies, offering promise for more effective, targeted, and durable treatments that may revolutionize the management of AMD and potentially prevent vision loss in affected individuals.
Age-related Macular Degeneration Companies in the Therapeutics Market Include:
Alkahest Inc, Alexion Pharmaceuticals, Allegro Ophthalmics, Alkeus Pharmaceuticals, Apellis Pharmaceuticals, AstraZeneca, Annexon Biosciences, Clearside Biomedical, CellCure Neurosciences, Evergreen Therapeutics, Gyroscope Therapeutics, Gemini Therapeutics, Graybug Vision, Ionis Pharmaceuticals, Iveric Bio, Kodiak Sciences Inc., Luxa Biotechnology, NGM Biopharmaceuticals, Novartis, Opthea Limited, Outlook Therapeutics, Inc., PanOptica, REGENXBIO, Regeneron Pharmaceuticals, Regenerative Patch Technologies, Ribomic USA Inc., Roche, Stealth BioTherapeutics, Unity Biotechnology Inc., and numerous other companies collectively contributing to the development of new therapies for the treatment of Age-related Macular Degeneration.
Emerging and Marketed Age-related Macular Degeneration (AMD) Therapies Covered in the Report Include:
• OPT-302: Opthea Limited
• KSI-301: Kodiak Sciences Inc.
• RGX-314: Regenxbio
• Danicopan (ALXN2040): Alexion Pharmaceuticals and AstraZeneca
• EG-301: Evergreen Therapeutics
• Pegcetacoplan: Apellis Pharmaceuticals
• Zimura: Iveric bio
• Luminate: Allegro Ophthalmics
• NGM621: NGM Biopharmaceuticals
• Elamipretide: Stealth BioTherapeutics
• CPCB-RPE1: Regenerative Patch Technologies
• OpRegen: CellCure Neurosciences/Lineage Cell Therapeutics/Roche
• GT005: Gyroscope Therapeutic
And Many Others
Get an in-depth Assessment of the Emerging Therapies and Age-related Macular Degeneration Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Report Introduction
2. Executive Summary
3. Age-related Macular Degeneration Current Treatment Patterns
4. Age-related Macular Degeneration - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Age-related Macular Degeneration Late-Stage Products (Phase-III)
7. Age-related Macular Degeneration Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Age-related Macular Degeneration Discontinued Products
13. Age-related Macular Degeneration Product Profiles
14. Age-related Macular Degeneration Companies
15. Age-related Macular Degeneration Drugs
16. Dormant and Discontinued Products
17. Age-related Macular Degeneration Unmet Needs
18. Age-related Macular Degeneration Future Perspectives
19. Age-related Macular Degeneration Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Biochips Market: https://www.delveinsight.com/report-store/biochips-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Pain Management Devices Market: https://www.delveinsight.com/report-store/pain-management-devices-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-epidemiology-forecast
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Ocular Motility Disturbance Market: https://www.delveinsight.com/report-store/ocular-motility-disturbance-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Age-related Macular Degeneration Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Opthea, Kodiak Sciences, Regenxbio, Alexion, AstraZeneca, Allegro, Apellis, Iveri here
News-ID: 3514269 • Views: …
More Releases from DelveInsight Business Research
Restrictive Cardiomyopathy Market: Pharma Pipeline Fuels Rapid Expansion by 2024 …
DelveInsight's "Restrictive Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Restrictive Cardiomyopathy, historical and forecasted epidemiology as well as the Restrictive Cardiomyopathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Restrictive Cardiomyopathy, offering comprehensive insights into the Restrictive Cardiomyopathy revenue trends, prevalence, and treatment landscape. The…
Heparin Induced Thrombocytopenia Market: Growth Momentum Across 7MM to 2034 - De …
The Heparin-induced Thrombocytopenia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Heparin-induced Thrombocytopenia market dynamics.
DelveInsight's "Heparin-induced Thrombocytopenia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Heparin-induced Thrombocytopenia, historical and forecasted epidemiology as well as the Heparin-induced Thrombocytopenia market trends in the United States, EU5…
Bronchopulmonary Dysplasia Market: Expanding Revenue Landscape to 2034 - DelveIn …
DelveInsight's "Bronchopulmonary Dysplasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bronchopulmonary Dysplasia, historical and forecasted epidemiology as well as the Bronchopulmonary Dysplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Bronchopulmonary Dysplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bronchopulmonary Dysplasia Market Forecast
https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key…
Erectile Dysfunction Market: Rapid Increment Driven by Innovation by 2034 - Delv …
DelveInsight's "Erectile Dysfunction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Erectile Dysfunction, historical and forecasted epidemiology as well as the Erectile Dysfunction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Erectile Dysfunction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Erectile Dysfunction Market Forecast
https://www.delveinsight.com/sample-request/erectile-dysfunction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
More Releases for Macular
Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degen …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Macular Edema and Macular Degeneration Market Size By 2025?
The market encompassing macular edema and macular degeneration has experienced substantial expansion recently, projected to increase from a value of $9.65 billion in 2024 to $10.33 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
How Large Will the Macular Edema and Macular Degeneration Market Size By 2025?
In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound…
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be?
The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in…
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies.
Download White Paper: https://www.towardshealthcare.com/download-statistics/5375
Market Overview and Key Drivers
The macular…
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $12.84…
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview
Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis
Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends
The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The…
